Pertuzumab was developed specifically to work alongside Trastuzumab, not instead of it — together they form what oncologists call "dual HER2 blockade," and this combination has become the preferred first-line approach for HER2-positive breast cancer wherever it's accessible. The two drugs bind to different sites on the HER2 receptor simultaneously, producing a more complete blockade of growth signaling than either antibody achieves alone, which translates into measurably higher rates of complete tumor response in clinical trials, particularly in the neoadjuvant (pre-surgery) setting.

• Approved indications: HER2-positive breast cancer — both neoadjuvant (pre-surgical) and metastatic treatment settings
• Mechanism: Binds domain II of the HER2 receptor, a different binding site from Trastuzumab, blocking HER2 dimerization with other HER-family receptors
• Clinical outcome data: Associated with significantly improved pathologic complete response rates when added to Trastuzumab and chemotherapy versus Trastuzumab and chemotherapy alone
• Order behavior: The vast majority of Pertuzumab orders we process are placed together with a corresponding Trastuzumab order, since the two are used in combination almost universally

Because Pertuzumab is essentially always given alongside Trastuzumab, its safety profile and monitoring requirements largely track with Trastuzumab's — but the combination does carry a marginally higher rate of certain side effects than Trastuzumab alone, which is worth flagging to prescribing teams.

• Age restriction: Not established for patients under 18
• Cardiac monitoring: Follows the same protocol as Trastuzumab, given near-universal co-administration
• Contraception requirement: Required during treatment and for a minimum of 6 months following the final dose
• Hepatic/renal caution: Use with caution and closer monitoring in patients with impaired liver or kidney function
• Diarrhea: More common with the Pertuzumab-Trastuzumab combination than with Trastuzumab alone — typically manageable but worth anticipating in patient counseling materials

Stock status: In stock for export, standalone or bundled with Trastuzumab

• Logistics: GDP-compliant cold-chain export (2–8°C)
• Coverage: LATAM, Africa, Middle East, Asia
• Cost efficiency: Co-shipping with Trastuzumab reduces total per-order logistics and documentation cost — a detail we proactively flag to distributors placing their first combined order
• Tracking: Full shipment tracking included

What is Pertuzumab used for?

Treats HER2-positive breast cancer, given alongside Trastuzumab and chemotherapy as part of dual HER2 blockade.

Get Pertuzumab price from a GMP-compliant Indian supplier — how?

Send strength and destination for a verified quote, ideally alongside your Trastuzumab requirement.

Can it be ordered together with Trastuzumab?

Yes, and we recommend it — combined orders reduce total shipping and documentation cost and simplify treatment scheduling.

Does it cause heart issues?

Cardiac function is monitored during treatment using the same protocol as Trastuzumab, since the two are almost always given together.

Who supplies Pertuzumab from India?

WHO-GMP certified export with full documentation, often sourced alongside Trastuzumab from the same manufacturer.